Molluscum contagiosum

From Wikipedia, the free encyclopedia

Jump to: navigation, search

Molluscum contagiosum
Classification and external resources

Typical flesh-colored, dome-shaped and pearly lesions ICD-10 ICD-9 DiseasesDB MedlinePlus eMedicine MeSH B08.1 078.0 8337 000826 derm/270 D008976

Molluscum contagiousm virus

EM of Molluscum contagiosum virus

Virus classification Group: Group I (dsDNA) Family: Poxviridae Genus: Molluscipoxvirus Species: Molluscum contagiosum virus

Molluscum contagiosum (MC) is a viral infection of the skin or occasionally of the mucous membranes. It is caused by a DNA poxvirus called the molluscum contagiosum virus (MCV). MCV has no animal reservoir, infecting only humans. There are four types of MCV, MCV-1 to -4; MCV-1 is the most prevalent and MCV-2 is seen usually in adults and often sexually transmitted. This common viral disease has a higher incidence in children, sexually active adults, and those who are immunodeficient,[1] and the infection is most common in children aged one to ten years old.[2] MC can affect any area of the skin but is most common on the trunk of the body, arms, and legs. It is spread through direct contact or shared items such as clothing or towels. The virus commonly spreads through skin-to-skin contact. This includes sexual contact or touching or scratching the bumps and then touching the skin. Handling objects that have the virus on them (fomites), such as a towel, can also result in infection. The virus can spread from one part of the body to another or to other people. The virus can be spread among children at day care or at school. Molluscum contagiosum is contagious until the bumps are gone-which, if untreated, may be up to 6 months or longer. The time from infection to the appearance of lesions can range up to 6 months, with an average incubation period between 2 and 7 weeks.[3]

Contents
[hide]

1 Diagnosis 2 Symptoms 3 Treatments

3.1 Cryotherapy 3.2 Astringents 3.3 Australian lemon myrtle 3.4 Benzoyl peroxide 3.5 Cantharidin 3.6 Tea tree oil 3.7 Over-the-counter substances 3.8 Imiquimod 3.9 Systemic treatments 3.10 Surgical treatment 3.11 Laser

4 Prognosis 5 See also 6 References 7 External links

Diagnosis

Low magnification micrograph of molluscum contagiosum. H&E stain.

High magnification micrograph of molluscum contagiosum, showing the characteristic molluscum bodies. H&E stain. Diagnosis is made on the clinical appearance; the virus cannot routinely be cultured. The diagnosis can be confirmed by excisional biopsy. Histologically, molluscum contagiosum is characterized by molluscum bodies in the epidermis above the stratum basale, which consist of large cells with: abundant granular eosinophilic cytoplasm (accumulated virons), and a small peripheral nucleus.

Symptoms
Molluscum contagiosum lesions are flesh-colored, dome-shaped, and pearly in appearance. They are often 15 millimeters in diameter, with a dimpled center. They are generally not painful, but they may itch or become irritated. Picking or scratching the bumps may lead to further infection or scarring. In about 10% of the cases, eczema develops around the lesions. They may occasionally be complicated by secondary bacterial infections. In some cases the dimpled section may bleed once or twice.[citation needed] The viral infection is limited to a localized area on the topmost layer of the epidermis.[4] Once the virus containing head of the lesion has been destroyed, the infection is gone. The central waxy core contains the virus. In a process called autoinoculation, the virus may spread to neighboring skin areas. Children are particularly susceptible to auto-inoculation, and may have widespread clusters of lesions.

Treatments
Individual molluscum lesions may go away on their own and are reported as lasting generally from 6 to 8 weeks,[5] to 2 or 3 months.[6] However via autoinoculation, the disease may propagate and so an outbreak generally lasts longer with mean durations variously reported as 8 months,[5] to about 18 months,[7][8] and with a range of durations from 6 months to 5 years.[6]
[8]

Treatment is often unnecessary[9] depending on the location and number of lesions, and no single approach has been convincingly shown to be effective. It should also be noted that treatments causing the skin on or near the lesions to rupture may spread the infection further, much the same as scratching does.[10] Nonetheless, treatment may be sought for the following reasons:

Molluscum lesions on an arm. Medical issues including: Bleeding Secondary infections Itching and discomfort Potential scarring

Chronic keratoconjunctivitis

Social reasons Cosmetic Embarrassment Fear of transmission to others Social exclusion

Many health professionals recommend treating bumps located in the genital area to prevent them from spreading.[8] The virus lives only in the skin and once the growths are gone, the virus is gone and cannot be spread to others. When treatment has resulted in elimination of all bumps, the infection has been effectively cured and will not reappear unless the patient is reinfected.[11] In practice, it may not be easy to see all of the molluscum contagiosum bumps. Even though they appear to be gone, there may be some that were overlooked. If this is the case, one may develop new bumps by autoinoculation, despite their apparent absence.

Cryotherapy
Cryotherapy involves killing infected cells by "freezing" them with a pressurized liquid spray, usually liquid nitrogen or nitrous oxide. The procedure can be mildly uncomfortable to painful depending on quantity and location of infected cells. The procedure can be performed by any medical professional.

Astringents
Astringent chemicals applied to the surface of molluscum lesions to destroy successive layers of the skin include trichloroacetic acid, podophyllin resin, potassium hydroxide, and cantharidin.[12]

Australian lemon myrtle

A 2004 study demonstrated over 90% reduction in the number of lesions in 9 out of 16 children treated once daily for 21 days with essential oil of Australian lemon myrtle

(Backhousia citriodora) dissolved in olive oil.[13] However the oil may irritate normal skin at concentrations of 1%.[14][15]

Benzoyl peroxide
In a small randomized controlled trial twice daily application of 10% benzoyl peroxide cream for 4 weeks was found to be more effective than tretinoin 0.05% cream; after 6 weeks 92% of the benzoyl peroxide group were lesion-free, compared with 45% of the tretinoin group (p = 0.02)[16][17]

Cantharidin
Cantharidin is a chemical found naturally in many members of the beetle family Meloidae which causes dermal blistering. Not FDA approved but available through Canada or select US compounding pharmacy. It is not painful on application, and so it might be preferred by some when treating small children. It should probably not be used near the eyes or in uncooperative children, as the chemical is caustic if scratched and rubbed on the eyes. It is usually applied with a wooden applicator like the sharp end of a wooden cotton bud. Some advocate leaving it on unoccluded. Some advocate covering it with tape for 1 to 8 hours.[18] Extreme caution should be used when administering Cantharidin. Despite the fact that it is used as an aphrodisiac in some countries, it is highly toxic to humans if ingested.[19]

Tea tree oil

Another essential oil, tea tree oil is reported to at least reduce growth and spread of lesions when used in dilute form.[20] Tea tree oil may cause contact dermatitis to those with sensitive skin, although less often in dilute form.

Over-the-counter substances
For mild cases, over-the-counter wart medicines, such as salicylic acid may or may not[21] shorten infection duration. Daily topical application of tretinoin cream ("Retin-A 0.025%") may also trigger resolution.[22][23] These treatments require several months for the infection to clear, and are often associated with intense inflammation and possibly discomfort.

Imiquimod
Doctors occasionally prescribe imiquimod, the optimum schedule for its use has yet to be established.[24] Imiquimod is a form of immunotherapy. Immunotherapy triggers the immune system to fight the virus causing the skin growth. Imiquimod is applied 3 times per week, left on the skin for 6 to 10 hours, and washed off. A cure may take from 4 to 16 weeks. Small studies have indicated that it is successful about 80% of the time. Another dose regimen: apply imiquimod three times daily for 5 consecutive days each week [25]. This is not FDAapproved treatment for molluscum contagiosum.

Systemic treatments
Cimetidine (however, double blind placebo studies seem to refute this[26]), Griseofulvin (single case, anecdotal evidence) and Methisazone have seen some use.[27]

Surgical treatment
Surgical treatments include cryosurgery, in which liquid nitrogen is used to freeze and destroy lesions, as well as scraping them off with a curette. Application of liquid nitrogen may cause burning or stinging at the treated site, which may persist for a few minutes after the treatment. Scarring or loss of color can complicate both these treatments. With liquid nitrogen, a blister may form at the treatment site, but it will slough off in two to four weeks. Although its use is banned by the FDA in the United States in its pure, undiluted form, the topical blistering agent cantharidin can be effective.[28] Cryosurgery and curette scraping are

not painless procedures. They may also leave scars and/or permanent white (depigmented) marks.

Laser
Pulsed dye laser therapy for molluscum contagiosum may be the treatment of choice for multiple lesions in a cooperative patient (Dermatologic Surgery, 1998). The use of pulsed dye laser for the treatment of MC has been documented with excellent results. The therapy was well tolerated, without scars or pigment anomalies. The lesions resolved without scarring at 2 weeks. Studies show 96%99% of the lesions resolved with one treatment.[29][30] The pulsed dye laser is quick and efficient, but its expense makes it less cost effective than other options. Also, not all dermatology offices have this 585 nm laser. It is important to remember that removal of the visible bumps does not cure the disease. The virus is in the skin and new bumps often appear over the course of a year until the body mounts an effective immune response to the virus. Thus any surgical treatment may require it to be repeated each time new crops of lesions appear.[citation needed]

Prognosis
Most cases of molluscum will clear up naturally within two years (usually within nine months). So long as the skin growths are present, there is a possibility of transmitting the infection to another person. When the growths are gone, the possibility for spreading the infection is ended.[11] Unlike herpes viruses, which can remain inactive in the body for months or years before reappearing, molluscum contagiosum does not remain in the body when the growths are gone from the skin and will not reappear on their own.[11] However, there is no permanent immunity to the virus, and it is possible to become infected again upon exposure to an infected person. Advantage of treatment is to hasten the resolution of the virus. This limits the size of the "pox" scar. If left untreated, molluscum growth can reach sizes as large as a pea or a marble. Spontaneous resolution of large lesions can occur, but will leave larger crater like growth. As many treatment options are available, prognosis for minimal scarring is best if treatment is initiated while lesions are small.

See also

Acrochordons (also called skin tags similar in appearance and grow in similar areas) Umbilicated lesions

References
1. ^ Hanson D, Diven DG (March 2003). "Molluscum contagiosum". Dermatology Online Journal 9 (2): 2. PMID 12639455. 2. ^ "Frequently Asked Questions: For Everyone. CDC Molluscum Contagiosum". United States Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dvrd/molluscum/faq/everyone.htm#whogets. Retrieved 2008-0629. 3. ^ "Dermatology Online Journal Volume 9 Number 2 - Molluscum Contagiosum". Daniel Hanson and Dayna G.Diven. http://dermatology.cdlib.org/92/reviews/molluscum/diven.html. Retrieved 2009-11-27. 4. ^ "Pamphlets: Molluscum Contagiosum". American Academy of Dermatology. 2006. http://www.aad.org/public/publications/pamphlets/viral_mollscum.html. Retrieved 2008-1130.

5. ^ a b Weller R, O'Callaghan CJ, MacSween RM, White MI (1999). "Scarring in Molluscum contagiosum: comparison of physical expression and phenol ablation". BMJ 319 (7224): 1540. PMID 10591712. PMC 28297. http://www.bmj.com/cgi/content/full/319/7224/1540. 6. ^ a b derm/270 at eMedicine 7. ^ MedlinePlus Encyclopedia 000826 8. ^ a b c Tyring SK (2003). "Molluscum contagiosum: the importance of early diagnosis and treatment". Am. J. Obstet. Gynecol. 189 (3 Suppl): S126. doi:10.1067/S00029378(03)00793-2. PMID 14532898. 9. ^ Prodigy knowledgebase (July 2003). "Molluscum Contagiosum". National Health Service. http://www.cks.nhs.uk/molluscum_contagiosum/management/scenario_molluscum_contagios um#341804006. Retrieved 2010-04-20. - UK NHS guidelines on Molluscum Contagiosum 10.^ van der Wouden JC, Menke J, Gajadin S, et al. (2006). "Interventions for cutaneous molluscum contagiosum". Cochrane Database Syst Rev (2): CD004767. doi:10.1002/14651858.CD004767.pub2. PMID 16625612. 11.^ a b c "Frequently Asked Questions: For Everyone. CDC Molluscum Contagiosum". United States Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dvrd/molluscum/faq/everyone.htm#howlongstay. Retrieved 200812-08. 12.^ "Molluscum Contagiosum - Treatment Overview". WebMD. January 12, 2007. http://www.webmd.com/skin-problems-and-treatments/tc/molluscum-contagiosum-treatmentoverview. Retrieved 2007-10-21. 13.^ Burke BE, Baillie JE, Olson RD (2004). "Essential oil of Australian lemon myrtle (Backhousia citriodora) in the treatment of molluscum contagiosum in children". Biomed. Pharmacother. 58 (4): 2457. doi:10.1016/j.biopha.2003.11.006. PMID 15183850. 14.^ Hayes AJ, Markovic B (2002). "Toxicity of Australian essential oil Backhousia citriodora (Lemon myrtle). Part 1. Antimicrobial activity and in vitro cytotoxicity". Food Chem. Toxicol. 40 (4): 53543. doi:10.1016/S0278-6915(01)00103-X. PMID 11893412. 15.^ Hayes AJ, Markovic B (2003). "Toxicity of Australian essential oil Backhousia citriodora (lemon myrtle). Part 2. Absorption and histopathology following application to human skin". Food Chem. Toxicol. 41 (10): 140916. doi:10.1016/S0278-6915(03)00159-5. PMID 12909275. 16.^ http://cks.library.nhs.uk/molluscum_contagiosum/evidence/supporting_evidence/treatments_u sed_in_secondary_care_for_molluscum_contagiosum 17.^ Saryazdi, S. (2004) The comparative efficacy of benzoyl peroxide 10% cream and tretinoin 0.05% cream in the treatment of molluscum contagiosum. Abstract 10th World Congress on Pediatric Dermatology. Pediatric Dermatology 21(3), 399. 18.^ http://www.emedsaver.com/index.php?pageID=0005&qryID=1&qry=Canthacur+Wart 19.^ http://molpharm.aspetjournals.org/content/33/6/706.full.pdf+html 20.^ aidsmap.com | Molluscum contagiosum 21.^ Molluscum contagiosum -Jochen Schmitt and Thomas L. Diepgen 22.^ Papa C, Berger R (1976). "Venereal herpes-like molluscum contagiosum: treatment with tretinoin". Cutis 18 (4): 53740. PMID 1037097. 23.^ Credo, BV; Dyment, PG (1996). "Molluscum Contagiosum". Adolesc Med 7 (1): 5762. PMID 10359957. 24.^ Hanna D, Hatami A, Powell J, et al. (2006). "A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in

children". Pediatric dermatology 23 (6): 5749. doi:10.1111/j.1525-1470.2006.00313.x. PMID 17156002. 25.^ Syed TA, Goswami J, Ahmadpour OA et al. (1998). "Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream". J Dermatol (25): 309313. 26.^ "Cimetidine: A review of the recent developments and reports in cutaneous medicine". Dermatology Online Journal. 2003. http://dermatology.cdlib.org/92/reviews/cimetidine/scheinfeld.html. Retrieved 2008-11-30. 27.^ "Molluscum Contagiosum". eMedicine from WebMD. 2007-05-31. http://www.emedicine.com/derm/TOPIC270.HTM. Retrieved 2008-11-30. 28.^ Although pure cantharidin and flexible collodion can be purchased as separate items and mixed by clinicians. See http://www.cfpc.ca/cfp/2003/Jul/vol49-jul-cme-2.asp 29.^ Hammes S, Greve B, Raulin C (2001). "Molluscum contagiosum: Treatment with pulsed dye laser" (in German). Der Hautarzt; Zeitschrift fr Dermatologie, Venerologie, und verwandte Gebiete 52 (1): 3842. PMID 11220237. 30.^ Hughes P (February 1998). "Treatment of molluscum contagiosum with the 585-nm pulsed dye laser". Dermatol Surg 24 (2): 22930. doi:10.1016/S1076-0512(97)00178-7. PMID 9491117.

External links

Molluscum Center for Disease Control Virus Pathogen Database and Analysis Resource (ViPR): Poxviridae [show]v d eDiseases of the skin and appendages by morphology Epidermal wart callus seborrheic keratosis acrochordon molluscum contagiosum actinic keratosis squamous cell carcinoma basal cell carcinoma merkel cell carcinoma nevus sebaceous trichoepithelioma Freckles lentigo melasma nevus melanoma epidermal inclusion cyst hemangioma dermatofibroma keloid lipoma neurofibroma xanthoma Kaposi's sarcoma infantile digital fibromatosis granular cell tumor leiomyoma lymphangioma circumscriptum myxoid cyst contact dermatitis atopic dermatitis seborrheic dermatitis stasis dermatitis lichen simplex chronicus Darier's disease glucagonoma syndrome langerhans cell histiocytosis lichen sclerosus pemphigus foliaceus Wiskott-Aldrich syndrome Zinc deficiency psoriasis tinea (corporis cruris pedis manuum faciei) pityriasis rosea secondary syphillis mycosis fungoides systemic lupus erythematosus pityriasis rubra pilaris parapsoriasis ichthyosis herpes simplex herpes zoster varicella bullous impetigo acute contact dermatitis pemphigus vulgaris bullous pemphigoid dermatitis herpetiformis porphyria cutanea tarda epidermolysis bullosa simplex

G r o Pigmented w t h Dermal and s subcutaneou s

R With a epidermal s involvemen Eczematous ht e s Scaling

Blistering

Papular

scabies insect bite reactions lichen planus miliaria keratosis pilaris lichen spinulosus transient acantholytic dermatosis lichen nitidus pityriasis lichenoides et varioliformis acuta acne vulgaris acne rosacea folliculitis impetigo candidiasis gonococcemia dermatophyte coccidioidomycosis subcorneal pustular dermatosis

Pustular

tinea versicolor vitiligo pityriasis alba postinflammatory hyperpigmentation tuberous sclerosis Hypopigmented idiopathic guttate hypomelanosis leprosy hypopigmented mycosis fungoides drug eruptions viral exanthems Generalized toxic erythema systemic lupus erythematosus Blanchable Erythema Red Without epidermal involvemen t Localized cellulitis abscess boil erythema nodosum carcinoid syndrome fixed drug eruption

urticaria erythema (multiforme Specialized migrans gyratum repens annulare centrifugum ab igne) thrombocytopenic purpura actinic Macular purpura Nonblanchable Purpura disseminated intravascular Papular coagulation vasculitis

Indurated MUlcers i s c Hair e l l Nail a n e Mucous o membran ue s

scleroderma/morphea granuloma annulare lichen sclerosis et atrophicus necrobiosis lipoidica

telogen effluvium androgenic alopecia trichotillomania alopecia areata systemic lupus erythematosus tinea capitis loose anagen syndrome lichen planopilaris folliculitis decalvans acne keloidalis nuchae onychomycosis psoriasis paronychia ingrown nail aphthous stomatitis oral candidiasis lichen planus leukoplakia pemphigus vulgaris mucous membrane pemphigoid cicatricial pemphigoid herpesvirus coxsackievirus syphilis systemic histoplasmosis squamous cell carcinoma

d i s o r d e r s [show]v d eSexually transmitted diseases and infections (STD/STI)

(primarily A50A64, 090099)

B a c t e r i a l

Chancroid (Haemophilus ducreyi) Chlamydia/Lymphogranuloma venereum (Chlamydia trachomatis) Donovanosis or Granuloma Inguinale (Klebsiella granulomatis) Gonorrhea (Neisseria gonorrhoeae) Syphilis (Treponema pallidum) Ureaplasma infection (Ureaplasma urealyticum)

P r o t o Trichomoniasis (Trichomonas vaginalis) z o a l P a r a s Crab louse/crabs Scabies i t i c V i AIDS (HIV-1/HIV-2) Cervical cancer & Genital warts (condyloma) (Human r papillomavirus (HPV)) Hepatitis B (Hepatitis B virus) Herpes a simplex (HSV1/HSV2) Molluscum contagiosum (MCV) l G female: Cervicitis Pelvic inflammatory disease (PID) e male: Epididymitis Prostatitis

n e r a l i n f either: Proctitis Urethritis/Non-gonococcal urethritis (NGU) l a m m a t i o n M: FRS anat/phys/devp noco/cong/npls, sysi/epon noco/cong/tumr, sysi/epon proc/asst, drug (G1/G2B/G3CD) proc, drug (G3B/4B/4C)

M: MRS

anat/phys/devp

[show]v d eInfectious skin disease: Viral cutaneous conditions, including

viral exanthema (B00B09, 050059)

DNA virus Herpesviridae AlphaHSV (Herpes simplex, Herpetic whitlow, Herpes gladiatorum, Herpetic keratoconjunctivitis, Herpetic sycosis, Neonatal herpes simplex, Herpes genitalis, Herpes labialis, Eczema herpeticum, Herpetiform esophagitis) Herpes B virus (B virus infection) VZV (Chickenpox, Herpes zoster, Herpes zoster oticus, Ophthalmic zoster, Disseminated herpes

zoster, Zosterassociated pain, Inflammatory skin lesions following zoster infection, Modified varicellalike syndrome) Human herpesvirus 6/Roseolovirus (Exanthema Betasubitum, Roseola vaccinia) Cytomegalic inclusion disease Gamma KSHV (Kaposi's sarcoma)

Variola (Smallpox, Eczema vaccinatum, Alastrim) MoxV (Monkeypox) CV Ortho(Cowpox) VV (Vaccinia, Generalized vaccinia, Progressive vaccinia) Buffalopox Poxviridae Farmyard pox: Milker's nodule Bovine papular Para stomatitis Pseudocowpox Orf Sealpox Yatapoxvirus: Tanapox Yaba Othermonkey tumor virus MCV (Molluscum contagiosum) PapillomaviridaHPV (Wart/Plantar wart, eHeck's disease, Genital wart (giant), Laryngeal papillomatosis, Butcher's wart, Bowenoid papulosis, Epidermodysplasia verruciformis, Verruca plana, Pigmented wart, Verrucae palmares et plantares )

BPV (Equine sarcoid) Parvovirus B19 (Erythema infectiosum, ParvoviridaeReticulocytopenia, Papular purpuric gloves and socks syndrome) Paramyxovirida MeV (Measles) e Rubella virus (Rubella, Congenital rubella Togaviridaesyndrome) Alphavirus infection Chikungunya fever CAV (Hand, foot and mouth disease, Herpangina) PicornaviridaeFMDV (Foot-and-mouth disease) Boston exanthem disease U n g r unknown/multiple: Asymmetric periflexural exanthem of childhood Post-vaccination o follicular eruption Lipschtz ulcer Eruptive pseudoangiomatosis Viral-associated u trichodysplasia GianottiCrosti syndrome p e d M: VIR virs (prot) cutn/syst (hppv, hiva, drugJ(dnaa, rnaa, rtva, infl, zost, zoon), epon vacc) noco(i, b, d, q, u, r, p, k, c, v)/cong/tumr(n, e, d), sysi/epon proc, drug (D2/3/4/5/8)

RNA virus

M: INT, SF, LCT

anat/phys/devp

Retrieved from "http://en.wikipedia.org/wiki/Molluscum_contagiosum" Categories: Poxviruses | Sexually transmitted diseases and infections | Virus-related cutaneous conditions Hidden categories: Articles with 'species' microformats | All articles with unsourced statements | Articles with unsourced statements from November 2008 | Articles with unsourced statements from February 2011
Personal tools

Log in / create account

Namespaces


Views

Article Discussion

Variants

Actions Search

Read View source View history

Top of Form

Special:Search Search
Bottom of Form

Navigation

Toolbox

Main page Contents Featured content Current events Random article Donate to Wikipedia Help About Wikipedia Community portal Recent changes Contact Wikipedia What links here Related changes Upload file Special pages Permanent link Cite this page Create a book Download as PDF Printable version

Interaction

Print/export

Languages

esky Deutsch Espaol Euskara Franais Italiano Latina Nederlands Norsk (bokml) Polski Portugus Romn Slovenina / Srpski Svenska This page was last modified on 8 February 2011 at 18:50. Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. See Terms of Use for details. Wikipedia is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization. Contact us Privacy policy About Wikipedia Disclaimers